Brain Research and Integrative Neuroscience Network for COVID-19
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-60
SponsorUniversity of Cyprus
About this trial
The aim of the experimental study is to investigate two interventions for the management of cognitive symptoms resulting from long COVID. Participants will be randomly assigned into two interventions. 1. Categorization Program (CP) training with active tDCS or 2. Categorization Program training with sham tDCS.
Eligibility criteria
Qualifiers
Reported cognitive difficulties due to COVID-19 infection
WHO Long COVID criteria will be used
Disqualifiers
Significant history of neuropsychiatric conditions prior to contracting COVID-19; history of neurological conditions such as TBI, CVA, MS prior to contracting COVID-19.
Trial design
Treatments tested in this trial
- Combination of tDCS (device) with cognitive training (behavioral)
- Categorization Program
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov